Publications by authors named "Gary Evoniuk"

Claim this Profile
A
Authors' reply to Spiegel and colleagues.
Gary Evoniuk, Bernadette Mansi, Barbara DeCastro, Jennie Sykes

BMJ· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
Gary Evoniuk, Bernadette Mansi, Barbara DeCastro, Jennie Sykes

BMJ· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A factor analytic study in bipolar depression, and response to lamotrigine.
Philip B Mitchell, Dusan Hadzi-Pavlovic, Gary Evoniuk, Joseph R Calabrese, Charles L Bowden

CNS Spectr· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
Emiliangelo Ratti, Paolo Bettica, Robert Alexander, Graeme Archer, David Carpenter, Gary Evoniuk

J Psychopharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
Susan Learned, Ole Graff, Suraja Roychowdhury, Rachel Moate, K Ranga Krishnan, Gary Evoniuk

J Psychopharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
David E Kemp, Stephen J Ganocy, Martin Brecher, Berit X Carlson, Suzanne Edwards, Gary Evoniuk

J Affect Disord· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Karen Hewett, Michelle D Gee, Alok Krishen, Hans-Peter Wunderlich, Alfred Le Clus, Gary Evoniuk

J Psychopharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Richard H Weisler, Joseph R Calabrese, Charles L Bowden, John A Ascher, Joseph DeVeaugh-Geiss, Gary Evoniuk

J Affect Disord· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
Charles L Bowden, Suzanne Edwards, Gary Evoniuk

CNS Spectr· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment outcomes in older patients with bipolar I disorder.
Martha Sajatovic, Laszlo Gyulai, Joseph R Calabrese, Thomas R Thompson, Barbara G Wilson, Gary Evoniuk

Am J Geriatr Psychiatry· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis